# Efficacy of Probiotic Lactobacillus Crispatus M247 in Promoting High-risk Human Papillomavirus (HR-HPV) Infection Clearance and Modifying Vaginal Microbiota

> **NCT06802809** · NA · COMPLETED · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 66 (actual)

## Conditions studied

- Human Papillomavirus Infection

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus crispatus M247 (Crispact®)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06802809
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-05
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2025-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06802809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06802809, "Efficacy of Probiotic Lactobacillus Crispatus M247 in Promoting High-risk Human Papillomavirus (HR-HPV) Infection Clearance and Modifying Vaginal Microbiota". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06802809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*